Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-20

Clinical Trial Update: The Safety Research of Freeze-dried Rabies Vaccine(MRC-5 Cell) in Chinese Humans [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety of a freeze-dried rabies vaccine derived from MRC-5 cells in healthy Chinese adults has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Freeze-dried Rabies Vaccine (MRC-5 Cell) (rabies vaccine, MRC-5 cell line)

Snippet

Sponsor: Beijing Center for Disease Control and Prevention | Conditions: Rabies, Healthy | Phase 1 | Status: COMPLETED